These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21652159)

  • 1. Analysis of co-spray-dried meloxicam-mannitol systems containing crystalline microcomposites.
    Pomázi A; Ambrus R; Sipos P; Szabó-Révész P
    J Pharm Biomed Anal; 2011 Sep; 56(2):183-90. PubMed ID: 21652159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of spray drying technique for improvement of dissolution and anti-inflammatory effect of Meloxicam.
    Shazly G; Badran M; Zoheir K; Alomrani A
    Pak J Pharm Sci; 2015 Jan; 28(1):103-11. PubMed ID: 25553688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Stability testing of meloxicam-containing microcomposites for inhalation].
    Pomázi A; Ambrus R; Szabóné Révész P
    Acta Pharm Hung; 2014; 84(2):55-62. PubMed ID: 25167700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicochemical characterization of meloxicam-mannitol binary systems.
    Nassab PR; Rajkó R; Szabó-Révész P
    J Pharm Biomed Anal; 2006 Jun; 41(4):1191-7. PubMed ID: 16621418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of an Optimized Wet Milling Technology on the Crystallinity, Morphology and Dissolution Properties of Micro- and Nanonized Meloxicam.
    Bartos C; Szabó-Révész P; Bartos C; Katona G; Jójárt-Laczkovich O; Ambrus R
    Molecules; 2016 Apr; 21(4):507. PubMed ID: 27110752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of oral lyophilisates containing meloxicam nanocrystals using QbD approach.
    Iurian S; Bogdan C; Tomuță I; Szabó-Révész P; Chvatal A; Leucuța SE; Moldovan M; Ambrus R
    Eur J Pharm Sci; 2017 Jun; 104():356-365. PubMed ID: 28435075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of protein on mannitol polymorphic form produced during co-spray drying.
    Hulse WL; Forbes RT; Bonner MC; Getrost M
    Int J Pharm; 2009 Dec; 382(1-2):67-72. PubMed ID: 19682563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced dissolution of megestrol acetate microcrystals prepared by antisolvent precipitation process using hydrophilic additives.
    Cho E; Cho W; Cha KH; Park J; Kim MS; Kim JS; Park HJ; Hwang SJ
    Int J Pharm; 2010 Aug; 396(1-2):91-8. PubMed ID: 20558265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid dispersion of meloxicam: factorially designed dosage form for geriatric population.
    Pathak D; Dahiya S; Pathak K
    Acta Pharm; 2008 Mar; 58(1):99-110. PubMed ID: 18337211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coformer selection in pharmaceutical cocrystal development: a case study of a meloxicam aspirin cocrystal that exhibits enhanced solubility and pharmacokinetics.
    Cheney ML; Weyna DR; Shan N; Hanna M; Wojtas L; Zaworotko MJ
    J Pharm Sci; 2011 Jun; 100(6):2172-81. PubMed ID: 21491441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of preparation parameters to improve the dissolution of poorly water-soluble meloxicam.
    Ambrus R; Kocbek P; Kristl J; Sibanc R; Rajkó R; Szabó-Révész P
    Int J Pharm; 2009 Nov; 381(2):153-9. PubMed ID: 19616609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo investigations on the binary meloxicam-mannitol system.
    Nassab PR; Blazsó G; Nyári T; Falkay G; Szabó-Révész P
    Pharmazie; 2008 Apr; 63(4):319-20. PubMed ID: 18468395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of spray-dried powders intended for pulmonary delivery of insulin with regard to the selection of excipients.
    Razavi Rohani SS; Abnous K; Tafaghodi M
    Int J Pharm; 2014 Apr; 465(1-2):464-78. PubMed ID: 24560646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid-state characterization and dissolution properties of meloxicam-moringa coagulant-PVP ternary solid dispersions.
    Noolkar SB; Jadhav NR; Bhende SA; Killedar SG
    AAPS PharmSciTech; 2013 Jun; 14(2):569-77. PubMed ID: 23483432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous and scalable process for water-redispersible nanoformulation of poorly aqueous soluble APIs by antisolvent precipitation and spray-drying.
    Hu J; Ng WK; Dong Y; Shen S; Tan RB
    Int J Pharm; 2011 Feb; 404(1-2):198-204. PubMed ID: 21056643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicochemical characterization and dissolution properties of meloxicam-cyclodextrin binary systems.
    Naidu NB; Chowdary KP; Murthy KV; Satyanarayana V; Hayman AR; Becket G
    J Pharm Biomed Anal; 2004 Apr; 35(1):75-86. PubMed ID: 15030882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roughness-controlled self-assembly of mannitol/LB agar microparticles by polymorphic transformation for pulmonary drug delivery.
    Zhang F; Ngoc NT; Tay BH; Mendyk A; Shao YH; Lau R
    Mol Pharm; 2015 Jan; 12(1):223-31. PubMed ID: 25423614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
    Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
    Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of inclusion complexation of meloxicam with β-cyclodextrin- and β-cyclodextrin-based nanosponges on solubility, in vitro release and stability studies.
    Shende PK; Gaud RS; Bakal R; Patil D
    Colloids Surf B Biointerfaces; 2015 Dec; 136():105-10. PubMed ID: 26364091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physical characterization and dissolution performance assessment of Etravirine solid dispersions prepared by spray drying process.
    Kommavarapu P; Maruthapillai A; Palanisamy K; Koya RT
    Pak J Pharm Sci; 2016 Nov; 29(6):2023-2031. PubMed ID: 28375119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.